No significant differences were identified between the HFD-BC and HFD groups for all the following parameters: glucose tolerance (IPGTT), fasting blood glucose levels, fasting plasma insulin concentrations, the white adipocytes area in eWAT, and NAFLD activity score (Supplemental Figures S2–S4). This evidence concerns the gene INS and breast cancer.